{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:26:52Z","timestamp":1787772412522,"version":"build-2784847793"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.4103\/ijd.ijd_531_21","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:15:14Z","timestamp":1716984914000},"page":"753-755","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Recurrent Oral and Genital Ulcers in Behcet's Disease with Rituximab"],"prefix":"10.4103","volume":"67","author":[{"given":"Alpana","family":"Mohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh Kumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Dutt","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20240829","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/0019-5154.113936","article-title":"Analysis of diagnostic criteria in adamantiades-beh\u00e7et disease: A retrospective study","volume":"58","author":"di Meo","year":"2013","journal-title":"Indian J Dermatol"},{"key":"R2-23-20240829","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/practneurol-2018-001899","article-title":"Rituximab in neurological disease: Principles, evidence and practice","volume":"19","author":"Whittam","year":"2019","journal-title":"Pract Neurol"},{"key":"R3-23-20240829","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/BOR.0000000000000458","article-title":"A review of current management of vasculo-Behcet's","volume":"30","author":"Merashli","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"R4-23-20240829","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-017-0681-6","article-title":"An update on the use of biologic therapies in the management of uveitis in Beh\u00e7et's disease: A comprehensive review","volume":"12","author":"McNally","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"R7-23-20240829","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1756-185X.2010.01546.x","article-title":"Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study)","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"R8-23-20240829","doi-asserted-by":"crossref","first-page":"577308","DOI":"10.1016\/j.jneuroim.2020.577308","article-title":"Rituximab as an effective therapeutic option in refractory Neuro-Beh\u00e7et syndrome","volume":"346","author":"Garcia-Estrada","year":"2020","journal-title":"J Neuroimmunol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_531_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:45:13Z","timestamp":1787769913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_531_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_531_21","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}